Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 2 Oct 2021)

 

Tolerability of MenACWY-TT vaccination in adolescents in the Netherlands; a cross-sectional study
In 2018, meningococcal ACWY-TT vaccine (MenACWY-TT) was offered to adolescents in the Netherlands within the National Immunization Programme at 14 years of age. A questionnaire study assessed the tolerability …
Authors: J. M. Kemmeren, L. van Balveren, A. Kant and H. de Melker
Citation: BMC Public Health 2021 21:1752
Content type: Research article
Published on: 26 September 2021